ProPhase Labs, Inc.
Period Ending Dec 31, 2013 Dec 31, 2012 Dec 31, 2011 Dec 31, 2010
Total Revenue 25,032 22,406 17,453 14,502
Cost of Revenue 8,361 8,154 6,171 5,672
Gross Profit 16,671 14,252 11,282 8,830
Operating Expenses
Research and Development 824 1,301 1,088 794
Sales, General and Admin. 15,431 14,049 12,932 11,630
Non-Recurring Items - - - -
Other - - - -
Operating Income 416 (1,098) (2,738) (3,594)
Income From Continuing Operations
Add'l Income/Expense Items 2 7 28 53
Earnings Before Interest and Tax 418 (1,091) (2,710) (3,541)
Interest Expense 13 - - -
Earnings Before Tax 405 (1,091) (2,710) (3,541)
Income Tax - - - (40)
Minority Interest - - - -
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations 405 (1,091) (2,710) (3,501)
Non Recurring Events
Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income 405 (1,091) (2,710) (3,501)
Preferred Stock and Other Adjustments - - - -
Net Income Applicable to Common Shareholders 405 (1,091) (2,710) (3,501)